Escalon Medical Corp. income statement ESMC

Annual Quarterly

In fiscal 2026, which ended Jun 30, 2026, Escalon Medical Corp. reported revenue of $12.7 million, up 5.7% from the year before. Net income was $4.0 million, a profit margin of 31.5%. Operating income came to $45,235, an operating margin of 0.4%. Diluted earnings per share were $0.27. Across the 10 fiscal years shown, revenue grew from $11.2 million in fiscal 2017 to $12.7 million in fiscal 2026, about 1.4% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Jun 30, 2026	FY 2025 Jun 30, 2025	FY 2024 Jun 30, 2024	FY 2023 Jun 30, 2023	FY 2022 Jun 30, 2022	FY 2021 Jun 30, 2021	FY 2020 Jun 30, 2020	FY 2019 Jun 30, 2019	FY 2018 Jun 30, 2018	FY 2017 Jun 30, 2017
Revenue	13 +5.7%	12 +0.5%	12 -1.6%	12 +13.8%	11 +2.2%	10 +11.4%	9 -2.4%	10 -15.6%	11 +1.5%	11 -3.0%
Cost of revenue	7 +9.7%	7 -4.4%	7 +2.0%	7 +9.9%	6 +0.9%	6 +16.3%	5 +4.0%	5 -20.7%	6 +3.6%	6 -1.9%
Gross profit	6 +1.1%	6 +7.1%	5 -6.1%	5 +19.0%	5 +4.1%	4 +5.4%	4 -9.2%	5 -9.3%	5 -1.0%	5 -4.2%
Research and development	1 -33.4%	1 +9.4%	1 -15.9%	1 -17.4%	1 +11.3%	1 -20.7%	1 +51.7%	1 +47.9%	1 -52.5%	1 -27.4%
Selling, general and administrative	5 +8.6%	5 +1.4%	5 +9.0%	4 +2.4%	4 +14.4%	4 -7.8%	4 -6.5%	4 -5.8%	4 -4.5%	5 -9.2%
Operating expenses	6 +2.7%	5 +2.4%	5 +5.0%	5 -1.5%	5 +13.8%	4	—	5 -0.3%	5	—
Operating income	0 -66.0%	0 +227.5%	-0 -121.8%	0 +201.8%	-0 -1295.0%	-0 +97.6%	-1 -453.3%	-0 -223.6%	0 +132.7%	-1 +45.0%
Interest income	0	—	—	0 -47.8%	0 -75.1%	0 -72.6%	0 -60.8%	0 +97.5%	0 +1319.6%	0 +82.7%
Interest expense	0 -67.1%	0	—	—	—	—	—	—	—	—
Other income (expense)	3 +10312.1%	-0 -33.2%	-0 +4.3%	-0 -104.4%	0 +2763.7%	-0 -102.4%	1 +25397.9%	0 -99.2%	0 +478.9%	-0 -791.2%
Pretax income	3	—	—	—	—	—	—	—	—	—
Income tax	-1	0	0	0	—	—	—	—	—	—
Net income	4 +3702.5%	0 +184.2%	-0 -127.4%	0 +2426.6%	0 +134.8%	-0 +92.0%	-1 -160.1%	-0 -142.8%	1 +180.3%	-1 +36.9%
Net income to common	2 +7062.8%	0 +115.9%	-0 -179.9%	0 +760.9%	-0 +67.6%	-0 +85.3%	-1 -132.8%	-0 -153.4%	1	—
Basic EPS	0.27	0.00 +100.0%	-0.02 -166.7%	0.03	0.00 +100.0%	-0.01 +88.9%	-0.09 -125.0%	-0.04 -157.1%	0.07	—
Diluted EPS	0.27	0.00 +100.0%	-0.02 -166.7%	0.03	0.00 +100.0%	-0.01 +88.9%	-0.09 -125.0%	-0.04 -166.7%	0.06	—
Weighted average shares, basic	7 +0.0%	7 +0.0%	7 +0.0%	7 +0.0%	7 +0.0%	7 +0.0%	7 +0.0%	7 -1.8%	8 -0.0%	8 +0.1%
Weighted average shares, diluted	15 +2.4%	14 +92.2%	7 -45.3%	14 +2.6%	13 +78.3%	7 +0.0%	7 +0.0%	7 -18.9%	9 +21.1%	8 +0.1%
Other measures
Depreciation and amortization	0 -40.3%	0 -17.8%	0 +1.8%	0 -6.7%	0 +8.1%	0 -10.5%	0 -0.1%	0 +1.9%	0 +7.2%	0 +86.3%
EBITDA	0 -60.3%	0 +392.6%	-0 -111.2%	1 +224.2%	-0 -3893.4%	0 +100.8%	-1 -565.4%	-0 -179.9%	0 +143.7%	-1 +47.9%
Interest coverage	6.06x	5.87x	—	—	—	—	—	—	—	—
Margins
Gross margin	43.73%	45.75%	42.95%	45.00%	43.04%	42.28%	44.70%	48.09%	44.75%	45.88%
Operating margin	0.36%	1.11%	-0.87%	3.93%	-4.39%	-0.32%	-14.89%	-2.63%	1.80%	-5.58%
Pretax margin	22.56%	—	—	—	—	—	—	—	—	—
Profit margin	31.51%	0.88%	-1.05%	3.75%	0.17%	-0.50%	-6.92%	-2.60%	5.12%	-6.47%
EBITDA margin	0.53%	1.42%	-0.49%	4.30%	-3.94%	0.11%	-14.36%	-2.11%	2.23%	-5.17%
Effective tax rate	-39.66%	—	—	—	—	—	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as: ESMC (OTC)
Fiscal year ends: June 30
Incorporated in: PA
Headquarters: Wayne, PA
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 862668

Other Electromedical & Electrotherapeutic Apparatus companies

All 31 Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.